Ocular Therapeutix, Inc.
OCUL
$10.04
-$0.06-0.59%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -39.08% | -50.74% | -37.43% | -43.21% | -56.65% |
| Total Depreciation and Amortization | 39.14% | 20.22% | 14.18% | 6.17% | 5.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 92.70% | 61.07% | -24.90% | -36.28% | -44.25% |
| Change in Net Operating Assets | -141.38% | -62.19% | 175.37% | 160.48% | 156.13% |
| Cash from Operations | -35.44% | -55.51% | -52.13% | -61.48% | -97.92% |
| Capital Expenditure | -386.05% | -396.93% | -832.45% | -506.67% | -102.27% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -404.97% | -392.55% | -822.36% | -498.25% | -94.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 317.97% | 3,601.61% | 69.14% | -73.18% | -74.40% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 317.97% | 3,601.61% | 69.14% | -73.18% | -77.11% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 402.68% | 337.72% | 75.87% | -126.05% | -117.45% |